Clinical Trials
5
Active:0
Completed:4
Trial Phases
4 Phases
Early Phase 1:1
Phase 1:1
Phase 2:1
+1 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (5 trials with phase data)• Click on a phase to view related trials
Not Applicable
2 (40.0%)Early Phase 1
1 (20.0%)Phase 1
1 (20.0%)Phase 2
1 (20.0%)First-in-human Safety Study of Hypoimmune Pancreatic Islet Transplantation in Adult Subjects With Type 1 Diabetes
- First Posted Date
- 2024-02-02
- Last Posted Date
- 2024-12-11
- Lead Sponsor
- Per-Ola Carlsson
- Target Recruit Count
- 2
- Registration Number
- NCT06239636
- Locations
- 🇸🇪
Uppsala University Hospital, Uppsala, Sweden
Evaluation of Safety and Diabetes Status Upon Oral Treatment With GABA in Patients With Longstanding Type-1 Diabetes
Phase 1
Completed
- Conditions
- Type 1 Diabetes Mellitus
- Interventions
- Drug: Gamma-Aminobutyric Acid (GABA)
- First Posted Date
- 2018-08-17
- Last Posted Date
- 2022-11-02
- Lead Sponsor
- Per-Ola Carlsson
- Target Recruit Count
- 35
- Registration Number
- NCT03635437
- Locations
- 🇸🇪
Uppsala University Hospital, Uppsala, Sweden
Brown Adipose Tissue in Type 1 Diabetes
Not Applicable
Completed
- Conditions
- Type1diabetes
- First Posted Date
- 2016-12-07
- Last Posted Date
- 2018-10-11
- Lead Sponsor
- Per-Ola Carlsson
- Target Recruit Count
- 11
- Registration Number
- NCT02984514
- Locations
- 🇸🇪
Uppsala University Hospital, Uppsala, Sweden
[11C]5-Hydroxy-tryptophan PET for Assessment of Islet Mass in Type 2 Diabetes
Not Applicable
Completed
- Conditions
- Type2 Diabetes
- First Posted Date
- 2016-11-18
- Last Posted Date
- 2018-01-30
- Lead Sponsor
- Per-Ola Carlsson
- Target Recruit Count
- 39
- Registration Number
- NCT02967354
Liraglutide Effect on Beta-cell Function in C-peptide Positive Type 1 Diabetes
Phase 2
Completed
- Conditions
- Type 1 Diabetes
- Interventions
- First Posted Date
- 2015-12-01
- Last Posted Date
- 2020-11-05
- Lead Sponsor
- Per-Ola Carlsson
- Target Recruit Count
- 18
- Registration Number
- NCT02617654
- Locations
- 🇸🇪
Uppsala University Hospital, Uppsala, Sweden
News
No news found